Commercial-stage precision care company Octave Bioscience has raised significant capital to support its multi-analyte blood testing approach for neurodegenerative diseases. The Menlo Park-based company announced $35.6 million in Series C equity financing plus a $15.5 million term loan from Silicon […]
Octave Bioscience Secures $35.6M to Expand MS Testing Platform Read More »
A telehealth company has announced a celebrity partnership to promote conversations about medical weight management. Ro, a direct-to-patient healthcare company, announced that 23-time Grand Slam champion Serena Williams has been using their platform to access GLP-1 medications and will serve
Tennis Champion Serena Williams Becomes GLP-1 Ambassador for Telehealth Company Ro Read More »
Bladder cancer’s high recurrence rate and lifelong monitoring requirements make it one of the most expensive cancers to manage globally. Hong Kong-based precision diagnostics company Codex Genetics recently announced an exclusive collaboration with Pacific Edge to bring non-invasive genomic urine
Codex Genetics Partners with Pacific Edge for Bladder Cancer Testing in Hong Kong Read More »
Tampa, Florida-based TuHURA Biosciences has completed its acquisition of Kineta, Inc., adding a Phase 2-ready VISTA-inhibiting monoclonal antibody to its pipeline of cancer immunotherapy treatments designed to overcome resistance mechanisms that limit current therapies. Key Points The acquisition positions TuHURA
The BC Centre for Excellence in HIV/AIDS (BC-CfE) hosted a national summit in early June to address a troubling reality: The latest available government statistics for 2023 show a 35% uptick in HIV cases in Canada compared to 2022. Key
Rising HIV Cases Signal Crisis in Canadian Prevention Efforts Read More »
Life sciences venture capital firms continue to evolve their approaches to translating academic research into commercial therapies. Boston-based 28 Capital, co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, announced the launch of a new platform focused on
Biotech VC Firm 28 Capital Emerges from Tiger Gene with New Platform Read More »
Brii Biosciences has secured complete ownership of BRII-179, a hepatitis B immunotherapy candidate, through an $18 million acquisition from VBI Vaccines and its creditors. The acquisition gives Brii full control over intellectual property, manufacturing, and supply while eliminating future milestone
Brii Biosciences BRII-179 Acquisition Read More »
Male fertility is an increasing concern, and in response, a startup, Legacy, has raised an additional $7.5M to scale sperm testing and storage. At-home kits are shipped directly to clients and then back to Legacy’s state-of-the-art andrology labs and cryo-storage
Legacy Raises $7.5M Investment to Scale Sperm Testing and Storage Read More »
Research at Penn Dental Medicine is uncovering unique properties of jaw stem cells. Unlike stem cells from other bones like hips, those from the maxilla and mandible have shown superior regenerative abilities. A deeper understanding could lead to potential advancements
Unlocking Jaw Stem Cells: Pioneering Repair and Regeneration Read More »
